Xarelto Lawsuit News: Study Suggests Xarelto-Aspirin Combo Can Increases Uncontrollable Bleeding Events


Xarelto Lawsuit Filings Allege The Blood Thinner Causes Internal Bleeding, Brain Bleeds, And Other Dangerous Bleeding Side Effects.

Xarelto lawsuit xarelto-lawsuit-side-effects-lawyerXarelto Lawsuit News: A recently published Xarelto blood thinner study indicates Xarelto paired with aspirin may increase the risk of major bleeding events. The blood thinner’s ability to cause significant and uncontrolled bleeding is also an allegation in more than 18,000 Xarelto lawsuits pending in the Eastern District of Louisiana.

The thousands of Xarelto lawsuits filed allege that patients taking Xarelto are at risk for intracranial bleeds, gastrointestinal bleeds, blood clots and other life-threatening side effects that require hospitalization. The plaintiffs accuse Xarelto’s makers, Bayer Healthcare and Janssen Pharmaceuticals, of failing to adequately warn that Xarelto lacks an antidote to reverse the blood thinner’s anti-clotting effects. (In Re: Xarelto Products Liability Litigation, Xarelto Lawsuit No. 2592)

“We continue to speak with men and women around the country who allege serious side effects from the blood thinner, as well as, fatal bleeding because there is no antidote to stop the bleeding,” says Dr. François Blaudeau, founder of Southern Med Law.
The firms Xarelto lawsuit attorneys are strong advocates for helping men and women who believe they have suffered serious bleeding events after taking Xarelto. If you or a loved one have experienced life-threatening bleeding or other complications believed to be associated with Xarelto, please contact Southern Med Law today at 205-547-5525 to learn more about your legal rights and to arrange for a free, no obligation Xarelto lawsuit review. You can also visit www.southernmedlaw.com for more information on blood thinner side-effects and to fill out an online form to have one of the attorneys contact you.

The Xarelto study states researchers conducted a double-blind trial, called COMPASS, consisting of 27,395 participants with stable atherosclerotic vascular disease. The study examined the efficacy of Xarelto in reducing the risk of cardiovascular death, stroke, or heart attack. Some participants were given Xarelto plus aspirin, some were given only Xarelto, and others were given only aspirin. Researchers found:

  • The Xarelto-aspirin combination reduced the risk of stroke by 42 percent, cardiovascular death by 22 percent, and heart attack by 14 percent.
  • Major bleeding was significantly higher in the Xarelto-aspirin group with 3.1 percent of participants experiencing a major bleed compared to 1.9 percent of those receiving aspirin alone. The bleeding lead to hospitalization, with most bleeding occurring in the gastrointestinal tract. There was no significant difference in fatal bleeds or intracranial bleeds.
  • Xarelto alone did not result in better cardiovascular outcomes than aspirin alone, and resulted in more major bleeding events.

The study was published August 27, in the New England Journal of Medicine.

Xarelto (rivaroxaban) is a prescription blood thinner approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. The anticoagulant is also used to treat deep vein thrombosis and pulmonary embolism, and to reduce the risk of forming a blood clot in the legs and lungs of patients who underwent knee or hip replacement surgery.

Xarelto is one of three prescription anticoagulants called new generation blood thinners when compared to warfarin (Coumadin, Jantoven), which had been the only FDA-approved blood thinner to prevent stroke in patients with atrial fibrillation since 1954. Xarelto, Eliquis, and Pradaxa are considered more convenient to take than warfarin because patients do not have to undergo routine blood monitoring as do patients taking warfarin. Xarelto and Eliquis do not have an antidote to reverse their anti-clotting effects. Warfarin uses Vitamin K to reverse its anti-clotting effects while Praxbind is used to reverse Pradaxa’s effects.

About Southern Med Law And Filing A Xarelto Bleeding Lawsuit

Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective attorney and advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
Medical Negligence/MedicalDevice/Pharma/Qui Tam

This entry was posted in Southern Med Law | Article and tagged , , , , , . Bookmark the permalink.